[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364520-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364520-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","monensin-inhibits-triple-negative-breast-cancer-in-mice-by-a-na-dependent-cytotoxic-action-unrelated-to-cytostatic-effects","Monensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+ -Dependent Cytotoxic Action Unrelated to Cytostatic Effects","","Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited treatment options and poor clinical outcomes. This study evaluates whether targeting Na+ homeostasis can suppress TNBC by using BALB/c mice inoculated with 4T1-Luc2 cells and treated with the Na+ ionophore monensin or vehicle. Monensin increases Na+ in tumor tissue, promotes extensive necrosis, and preserves healthy organ structure and function. Cytotoxicity is preceded by intracellular Na+ accumulation and is prevented under Na+-free conditions, indicating a Na+-dependent, tumor-specific cytotoxic mechanism without cytostatic effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/monensin-inhibits-triple-negative-breast-cancer-in-mice-by-a-na-dependent-cytotoxic-action-unrelated-to-cytostatic-effects/364520/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/monensin-inhibits-triple-negative-breast-cancer-in-mice-by-a-na-dependent-cytotoxic-action-unrelated-to-cytostatic-effects/364520.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main therapeutic idea tested in this study?","Question",{"text":63,"@type":64},"The study tests whether targeting Na+ homeostasis can inhibit triple-negative breast cancer by inducing Na+-dependent cytotoxicity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the TNBC model and treatment administered?",{"text":68,"@type":64},"BALB/c mice were inoculated with 4T1-Luc2 breast cancer cells and treated with the Na+ ionophore monensin (8 mg/kg) or vehicle alone.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports a Na+-dependent, tumor-specific cytotoxic mechanism?",{"text":72,"@type":64},"Monensin increases intracellular Na+ in tumor tissue and triggers extensive necrosis, while Na+-free conditions prevent both Na+ accumulation and 4T1-Luc2 cell death.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364520,1792188989,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Article  \nMonensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+ -Dependent Cytotoxic Action Unrelated to Cytostatic Effects  \nSimone Fiorilla †, Francesco Tasso †, Nausicaa Clemente †, Tommaso Trisciuoglio, Renzo Boldorini and Rita Carini *  \nAcademic Editor: Zhixiang Wang  \nReceived: 15 December 2024  \nRevised: 11 January 2025  \nAccepted: 22 January 2025  \nPublished: 25 January 2025  \nCitation: Fiorilla, S.; Tasso, F.;  \nClemente, N.; Trisciuoglio, T.; Boldorini, R.; Carini, R. Monensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+-Dependent Cytotoxic Action Unrelated to Cytostatic Effects. Cells 2025, 14, 185. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cells14030185](10.3390/cells14030185)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nDepartment of Health Science, Università del Piemonte Orientale, Via Solaroli, 17, 28100 Novara, Italy;  \nsimone.fiorilla@uniupo.it (S.F.); francesco.tasso@uniupo.it (F.T.); nausicaa.clemente@med.uniupo.it (N.C.); [tommaso.trisciuoglio@uniupo.it](tommaso.trisciuoglio@uniupo.it) (T.T.); [renzo.boldorini@med.uniupo.it](renzo.boldorini@med.uniupo.it) (R.B.)  \n* Correspondence: rita.carini@med.uniupo.it † These authors contributed equally to this work.  \nAbstract: Triple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype, defined by its limited therapeutic options and poor outcomes. This study investigated the therapeutic potential of targeting Na+ homeostasis in TNBC cells to induce TNBC inhibition. For this purpose, BALB/c mice were inoculated with 4T1-Luc2 breast cancer cells and treated with the Na+ ionophore monensin (8 mg/kg) or vehicle alone. Tumor development and cellular Na+ content were assessed using vivo live imaging techniques, while intracellular Na+ variations and cytotoxicity were evaluated through live cell analysis. Monensin treatment increased Na+ levels in cancerous tissues and reduced TNBC mass (monensin: 0 .146 ± 0.06; vehicle: 0 .468 ± 0.2 cm3; p \u003C 0 .001) . This treatment induced extensive necrosis in TNBC tumors while preserving the structural and functional integrity of healthy organs and maintaining the proliferative activity of both tumor and normal tissues. Monensin did not alter the expression of proliferating nuclear antigen (PCNA) in 4T1-Luc2 cells but triggered cytotoxicity preceded by intracellular Na+ accumulation. Na+-free conditions prevented both Na+ accumulation and 4T1-Luc2 cell death. Thus, monensin exerts its antitumor effects in TNBC through a Na+-dependent and tumor-specific cytotoxic mechanism, without inducing cytostatic effects on normal or transformed tissues. Collectively, these findings underscore the potential of Na+ ionophores as promising therapeutic agents for TNBC.  \nKeywords: Na+ ionophores; cancer cell death; anticancer treatment  \n1. Introduction  \nBreast cancer is the most prevalent malignancy globally, with triple-negative breast cancer (TNBC) accounting for 15–20% of all diagnoses [1] . TNBC is characterized by the absence of estrogen and progesterone receptors, along with human epidermal growth factor receptor 2 (HER2) [2], making it unresponsive to hormone and HER2-targeted therapies that benefit other breast cancer subtypes [3] . As a result, treatment options for TNBC are largely confined to surgery and chemotherapy. Nonetheless, the high recurrence rates and limited overall survival (OS) associated with these approaches make the development of more effective therapeutic strategies a pressing priority [4,5] .  \nThis unmet clinical need is even more apparent if we consider that current advancements with poly (ADP-ribose) polymerase (PARP) inhibitors and immune checkpoint ","cbCaiqCgOry29k94","https://ap.wps.com/l/cbCaiqCgOry29k94","pdf",31570776,"English","# Introduction\n## Triple-negative breast cancer clinical challenge\n## Limitations of current TNBC therapies\n## Cancer metabolism and Na+-dependent pH regulation\n## Study hypothesis based on intracellular Na+ vulnerability","[{\"question\":\"What is the main therapeutic idea tested in this study?\",\"answer\":\"The study tests whether targeting Na+ homeostasis can inhibit triple-negative breast cancer by inducing Na+-dependent cytotoxicity.\"},{\"question\":\"How was the TNBC model and treatment administered?\",\"answer\":\"BALB/c mice were inoculated with 4T1-Luc2 breast cancer cells and treated with the Na+ ionophore monensin (8 mg/kg) or vehicle alone.\"},{\"question\":\"What evidence supports a Na+-dependent, tumor-specific cytotoxic mechanism?\",\"answer\":\"Monensin increases intracellular Na+ in tumor tissue and triggers extensive necrosis, while Na+-free conditions prevent both Na+ accumulation and 4T1-Luc2 cell death.\"}]","Monensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+ -Dependent Cytotoxic Action Unrelated to Cytostatic Effects | PDF",1790157924,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e9c52f918fc5302770f706c33d9d8cb.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd138258cfbedd738be28ca22ca9d19a.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9aae46f8b3c8e0d9dff57eace485c818.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c35cfc34da8fe01641cab3758f84c87.webp",980,1385]